|
Implantable iontophoresis chemotherapy delivery device for direct infusion of gemcitabine into pancreatic adenocarcinoma: Device development and First-in-Human clinical trial
|
4R44CA224460-02
|
$1,111,364
|
|
DAUNCH, WILLIAM
|
ADVANCED CHEMOTHERAPY TECHNOLOGIES, INC.
|
|
Colon cancer risk-stratification via optical analysis of rectal ultrastructure
|
3R44CA199667-02S2
|
$126,060
|
|
WALI, RAMESH
|
AMERICAN BIOOPTICS, LLC
|
|
Imaging and Radiation Oncology Core (IROC) Group
|
3U24CA180803-05S1
|
$335,460
|
|
FOLLOWILL, DAVID
|
AMERICAN COLLEGE OF RADIOLOGY
|
|
Impact of aging on prostate cancer with TMPRSS2-ETS gene fusion
|
4UH3CA213392-03
|
$75,000
|
|
LI, ZHE
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
c-Abl-mediated Suppression of Breast Cancer Development and Metastasis
|
3R01CA177069-05S1
|
$75,000
|
|
SCHIEMANN, WILLIAM
|
CASE WESTERN RESERVE UNIVERSITY
|
|
Clinical evaluation of the novel, uni-directional, Pd-103 CivaSheet for Lung Cancer
|
4R44CA217587-02
|
$1,165,750
|
|
PEREZ, KRISTY
|
CIVATECH ONCOLOGY, INC.
|
|
Molecular MR Imaging of the Desmoplastic Response in Pancreatic Cancer
|
3R44CA200186-03S1
|
$209,717
|
|
HUMBLET, VALERIE
|
COLLAGEN MEDICAL, LLC
|
|
Inflammation and Cardiovascular Disease in Rheumatoid Arthritis
|
3R01AR050026-13S1
|
$53,333
|
|
BATHON, JOAN
|
COLUMBIA UNIVERSITY HEALTH SCIENCES
|
|
Non-melanoma skin cancer: A model for impact of aging on an environmental disease
|
4UH3CA213384-03
|
$126,495
|
|
BICKERS, DAVID
|
COLUMBIA UNIVERSITY HEALTH SCIENCES
|
|
Cancer Center Support Grant
|
3P30CA013696-44S8
|
$126,563
|
|
SCHWARTZ, GARY
|
COLUMBIA UNIVERSITY HEALTH SCIENCES
|
|
Cancer Center Support Grant
|
3P30CA013696-44S9
|
$250,000
|
|
SCHWARTZ, GARY
|
COLUMBIA UNIVERSITY HEALTH SCIENCES
|
|
Dana-Farber/Harvard Cancer Center
|
3P30CA006516-53S6
|
$228,108
|
|
GLIMCHER, LAURIE
|
DANA-FARBER CANCER INST
|
|
Dana-Farber/Harvard Cancer Center
|
3P30CA006516-53S7
|
$199,806
|
|
GLIMCHER, LAURIE
|
DANA-FARBER CANCER INST
|
|
Duke-UNC-Wash U Partnership for Early Phase Clinical Trials in Cancer
|
3UM1CA186704-04S1
|
$170,500
|
|
ABBRUZZESE, JAMES
|
DUKE UNIVERSITY
|
|
Cancer Center Support Grant
|
3P30CA014236-44S4
|
$119,106
|
|
KASTAN, MICHAEL
|
DUKE UNIVERSITY
|
|
The Mathematics of Breast Cancer Overtreatment: Improving Treatment Choice through Effective Communication of Personalized Cancer Risk
|
4R00CA207872-03
|
$248,995
|
|
RYSER, MARC
|
DUKE UNIVERSITY
|
|
Winship Cancer Institute Cancer Center Support Grant
|
3P30CA138292-10S3
|
$234,000
|
|
CURRAN, WALTER
|
EMORY UNIVERSITY
|
|
Cancer Center Support Grant
|
3P30CA015704-43S5
|
$33,324
|
|
GILLILAND, D
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
Impact of aging on progression and prevention of mammary preneoplasia and cancer
|
4UH3CA213388-03
|
$138,278
|
|
FURTH, PRISCILLA
|
GEORGETOWN UNIVERSITY
|
|
DNA Methyltransferase Target Sites in Cancer
|
1F31CA171727-01A1
|
$36,942
|
$3,694
|
Tiedemann, Rochelle
|
GEORGIA REGENTS UNIVERSITY
|
|
Ex vivo culture platform validation for preservation of patient derived multiple myeloma cells
|
3R33CA212806-02S1
|
$121,845
|
|
ZILBERBERG, JENNY
|
HACKENSACK UNIVERSITY MEDICAL CENTER
|
|
A novel diagnostic biomarker for Hepatocellular Carcinoma(HCC)
|
3R44CA165314-04S1
|
$1,400
|
|
LU, XUANYONG
|
IMCARE BIOTECH
|
|
Cancer Center Support (CORE) Grant
|
3P30CA034196-33S1
|
$150,000
|
|
LIU, EDISON
|
JACKSON LABORATORY
|
|
Microparticulate mucosal vaccine for triple-negative breast cancer
|
3R41CA206652-01A1S1
|
$2,000
|
|
MIRANDOLA, LEONARDO
|
KIROMIC, INC.
|
|
Cancer Center Support (Core) Grant
|
5P30CA014051-42
|
$3,603,798
|
$36,038
|
JACKS, TYLER
|
MASSACHUSETTS INSTITUTE OF TECHNOLOGY
|
|
Chemistry and Biology of Platinum Anticancer Drugs
|
5R01CA034992-31
|
$639,282
|
$127,856
|
Lippard, Stephen
|
MASSACHUSETTS INSTITUTE OF TECHNOLOGY
|
|
Novel Bone-Targeting Combination Therapy for Osteosarcoma Phase II
|
3R44CA203166-03S1
|
$136,623
|
|
ZINNEN, SHAWN
|
MBC PHARMA, INC.
|
|
Annual anal sampling using DNA screening to identify men who have sex with men at increased risk for anal cancer
|
7R01CA215403-02
|
$551,568
|
|
NYITRAY, ALAN
|
MEDICAL COLLEGE OF WISCONSIN
|
|
Robust Predictor of Breast Cancer Risk
|
3R41CA217383-01A1S1
|
$2,000
|
|
OSTRER, HARRY
|
MORGAN AND MENDEL GENOMICS, INC.
|
|
Extramural Support
|
RMS2013 [E]
|
$366,054,072
|
$8,243
|
N/A
|
National Cancer Institute
|
|
Defining the urban-rural continuum and distinguishing rural differences to prevent tobacco use
|
3R21CA205589-02S1
|
$146,947
|
|
STILLMAN, FRANCES
|
NATIONAL OPINION RESEARCH CENTER
|
|
ATBC Study
|
ZIA CP010195-03031
|
$1,207,080
|
$12,071
|
Albanes, Demetrius
|
DCEG (NCI)
|
|
Biological Implications and Translational Applications of HDMX Inhibition
|
ZIA BC 011261
|
$51,885
|
$5,189
|
Bernal, Federico
|
CCR (NCI)
|
|
Laboratory of Translational Genomics
|
ZIA CP010201-10410
|
$1,892,992
|
$189,299
|
Chanock, Stephen
|
DCEG (NCI)
|
|
Growth curve analysis and urogenital cancers
|
ZIA CP010158-10628
|
$3,949
|
$1,303
|
Cook, Michael
|
DCEG (NCI)
|
|
ITCLC Familial Testicular Cancer Projects
|
ZIA CP010144-07160
|
$128,713
|
$128,713
|
Greene, Mark
|
DCEG (NCI)
|
|
Chromatin Structure and Gene Expression
|
ZIA BC 005450
|
$1,467,577
|
$220,137
|
Hager, Gordon
|
CCR (NCI)
|
|
Function of Steroid Receptors in Subcellular Compartments
|
ZIA BC 010027
|
$489,192
|
$97,838
|
Hager, Gordon
|
CCR (NCI)
|
|
In vivo Imaging Analysis of Steroid/Nuclear Receptor Function
|
ZIA BC 010308
|
$244,596
|
$24,460
|
Hager, Gordon
|
CCR (NCI)
|
|
Continuation of follow-up of DES-exposed cohorts
|
ZIA CP010168-00020
|
$2,241,379
|
$224,138
|
Hoover, Robert
|
DCEG (NCI)
|
|
Pregnancy hormone levels in maternal and cord blood: associations with maternal a
|
ZIA CP010168-01132
|
$9
|
$0
|
Hoover, Robert
|
DCEG (NCI)
|
|
Urologic Oncology Branch Consult Core
|
ZID BC 011092
|
$2,192,713
|
$109,636
|
Linehan, W. Marston
|
CCR (NCI)
|
|
Clinical and genetic studies of familial testicular cancer
|
ZIA CP010144-07070
|
$367,585
|
$367,585
|
Loud, Jennifer
|
DCEG (NCI)
|
|
Collaborative Perinatal Project
|
ZIA CP010126-01048
|
$26,041
|
$26,041
|
McGlynn, Katherine
|
DCEG (NCI)
|
|
Testicular cancer among US Servicemen
|
ZIA CP010126-01202
|
$237,234
|
$237,234
|
McGlynn, Katherine
|
DCEG (NCI)
|
|
Testicular methylation
|
ZIA CP010126-10442
|
$37,431
|
$37,431
|
McGlynn, Katherine
|
DCEG (NCI)
|
|
TECAC
|
ZIA CP010126-10533
|
$47,894
|
$47,894
|
McGlynn, Katherine
|
DCEG (NCI)
|
|
Radiation dose- response and second primary cancers of stomach, esophagus, and pa
|
ZIA CP010131-04134
|
$389,276
|
$38,928
|
Morton, Lindsay
|
DCEG (NCI)
|
|
Clinical Fellowship Training Program
|
ZIE BC 011023
|
$276,895
|
$13,845
|
Pinto, Peter
|
CCR (NCI)
|
|
Studies in the Janus Cohort
|
ZIA CP010120-02135
|
$72,896
|
$6,561
|
Rothman, Nat
|
DCEG (NCI)
|
Total relevant funding to Testes for this search: $5,864,134
|